Your browser doesn't support javascript.
loading
Initial assessment of the COVID-19 vaccination's impact on case numbers, hospitalisations and deaths in people aged 80 years and older, 15 EU/EEA countries, December 2020 to May 2021.
Nicolay, Nathalie; Innocenti, Francesco; Beauté, Julien; Ucakar, Veronika; Grgic Vitek, Marta; Poukka, Eero; Hannila-Handelberg, Tuula; Gauci, Charmaine; Melillo, Tanya; Georgakopoulou, Theano; Jarkovsky, Jiri; Slezak, Pavel; Delgado-Sanz, Concepción; Olmedo-Lucerón, Carmen; Suija, Heleene; Liausediene, Rasa; O'Lorcain, Piaras; Murphy, Niamh; Peralta-Santos, André; Casaca, Pedro; Gregoriou, Ioanna; Bundle, Nick; Spiteri, Gianfranco; Ravasi, Giovanni.
Afiliação
  • Nicolay N; European Centre for Disease Prevention and Control (ECDC), Solna, Sweden.
  • Innocenti F; European Centre for Disease Prevention and Control (ECDC), Solna, Sweden.
  • Beauté J; Epidemiology Unit, Regional Health Agency of Tuscany, Florence, Italy.
  • Ucakar V; European Centre for Disease Prevention and Control (ECDC), Solna, Sweden.
  • Grgic Vitek M; National institute of Public Health, Ljubljana, Slovenia.
  • Poukka E; National institute of Public Health, Ljubljana, Slovenia.
  • Hannila-Handelberg T; Finnish Institute for Health and Welfare, Helsinki, Finland.
  • Gauci C; Finnish Institute for Health and Welfare, Helsinki, Finland.
  • Melillo T; Health Promotion and Disease Prevention Directorate, Msida, Malta.
  • Georgakopoulou T; Health Promotion and Disease Prevention Directorate, Msida, Malta.
  • Jarkovsky J; Department of Epidemiological Surveillance and Intervention of the National Public Health Organization (NPHO), Athens, Greece.
  • Slezak P; Data analysis department, Institute of Health Information and Statistics of the Czech Republic, Prague, Czechia.
  • Delgado-Sanz C; Department of Infectious Diseases Epidemiology, National Institute of Public Health, Prague, Czechia.
  • Olmedo-Lucerón C; National Epidemiology Centre, CIBERESP, Institute of Health Carlos III, Madrid, Spain.
  • Suija H; Area Immunisation Programme. Ministry of Health, Madrid, Spain.
  • Liausediene R; Department of Communicable Diseases, Health Board, Tallin, Estonia.
  • O'Lorcain P; National Public Health Centre, Vilnius, Lithuania.
  • Murphy N; Health Protection Surveillance Centre, Dublin, Ireland.
  • Peralta-Santos A; Health Protection Surveillance Centre, Dublin, Ireland.
  • Casaca P; Directorate of Information and Analysis, Directorate-General of Health, Lisbon, Portugal.
  • Gregoriou I; Directorate of Information and Analysis, Directorate-General of Health, Lisbon, Portugal.
  • Bundle N; Ministry of Health, Nicosia, Cyprus.
  • Spiteri G; European Centre for Disease Prevention and Control (ECDC), Solna, Sweden.
  • Ravasi G; European Centre for Disease Prevention and Control (ECDC), Solna, Sweden.
Euro Surveill ; 26(48)2021 12.
Article em En | MEDLINE | ID: mdl-34857068
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Limite: Aged / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Limite: Aged / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article